JNM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Abstract Freely available
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Yu, M.-D.
Right arrow Articles by Shaw, S. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Yu, M.-D.
Right arrow Articles by Shaw, S. M.

The Effect of Formulation on Reduced Radioiodide Thyroid Uptake

Ming-Der Yu, PhD1, Wen-Sheng Huang, MD1, Chiou-Chi Cherng, MD1 and Stanley M. Shaw, PhD2

1 Department of Nuclear Medicine, Tri-Service General Hospital and National Defense University, Taipei, Taiwan
2 School of Pharmacy, Purdue University, West Lafayette, Indiana



View larger version (16K):

[in a new window]
  		FIGURE 1. Dissolution profiles for 131I sodium phosphate dibasic powder with 1% magnesium stearate (A) and calcium phosphate dibasic powder with 3% magnesium stearate (B).

 




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
JOURNAL OF NUCLEAR MEDICINE TECHNOLOGY THE JOURNAL OF NUCLEAR MEDICINE
Copyright © 2002 by the Society of Nuclear Medicine.